May 17, 2024

Animal Vaccine Market Size to Grow US$ 36.91 Billion By 2032

The global animal vaccine market size was approximate at US$ 14.27 billion in 2022 and is anticipated to grow US$ 36.91 billion by 2032, registering a compound annual growth rate of 9.97% from 2023 to 2032.

Animal Vaccine Market Size 2023 To 2032

The animal vaccine market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the animal vaccine market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2032.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2023 g0066ztr to 2032. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the animal vaccine report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the animal vaccine market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2958

Animal Vaccine Market Report Scope

Report Coverage Details
Market Size in 2023 USD 15.69 Billion
Market Size by 2032 USD 36.91 Billion
Growth Rate from 2023 to 2032 CAGR of 9.97%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Product Type, By Animal Type, By Route of Administration, and By End User
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Also read: Smart Sensors Market Size to Grow US$ 231.04 Billion By 2032

Research Approach

The comprehensive report on the global animal vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global animal vaccine market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

  • Merck & Co., Inc.
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Virbac
  • Biogénesis Bagó
  • Indian Immunologicals Ltd.
  • Elanco
  • Ceva
  • Phibro Animal Health Corporation
  • Neogen Corporation
  • Intas Pharmaceuticals Ltd.
  • Ourofino Saúde Animal

Market Segmentations

By Product Type

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Animal Type

  • Livestock
    • Poultry
    • Aqua
    • Ruminants
    • Swine
  • Companion
    • Canine
    • Feline

By Route of Administration

  • Subcutaneous
  • Intramuscular
  • Intranasal

By End User

  • Hospital
  • clinics

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Vaccine Market 

5.1. COVID-19 Landscape: Animal Vaccine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Vaccine Market, By Product Type

8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type, 2023-2032

8.1.1. Attenuated Live Vaccines

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Inactivated Vaccines

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Subunit Vaccines

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. DNA Vaccines

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Recombinant Vaccines

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Animal Vaccine Market, By Animal Type

9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type, 2023-2032

9.1.1. Livestock

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Companion

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Animal Vaccine Market, By Route of Administration 

10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration, 2023-2032

10.1.1. Subcutaneous

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Intramuscular

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Intranasal

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Animal Vaccine Market, By End User 

11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User, 2023-2032

11.1.1. Hospital

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. clinics

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Animal Vaccine Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)

12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)

12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)

12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)

Chapter 13. Company Profiles

13.1. Merck & Co., Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Zoetis

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Boehringer Ingelheim International GmbH

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Virbac

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Biogénesis Bagó

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Indian Immunologicals Ltd.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Elanco

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Ceva

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Phibro Animal Health Corporation

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Neogen Corporation

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global animal vaccine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for animal vaccine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *